Technology

The Isovue (iopamidol injection) Imaging Bulk Package (IBP) from Bracco Imaging Inc. is a specific combination multi-patient, multi-dose compliant contrast medium approved by the U.S....

Lumason (sulfur hexafluoride lipid microsphere) is a contrast agent for patients whose ultrasound image of the heart (echocardiograms) are hard to see with ultrasound waves....

Mallinckrodt U.S. Launch OptiSync Contrast Data Management System

Mallinckrodt's OptiSync data management system is designed to help healthcare professionals efficiently colle...

Positron Corp PosiRx 3000-Series Pharmacy Automation Systems

The PosiRx 3000-Series is Positron Corp.'s latest pharmacy automation systems....

October 26, 2011 – Lantheus Medical Imaging announced it has been awarded three-year supplier contracts with Premier Purchasing Partners, the group purchasing unit of the Premier healthcare allianc...

The Titan 3T is a works-in-progress magnetic resonance (MR) system from Toshiba. The system has several patient-friendly features that are designed to improve the exam experience.

...

Bracco offers contrast imaging agents for computed tomography (CT), magnetic resonance imaging (MRI), angiography and radiotracers for nuclear imaging.

...

The ultrasound contrast agent Optison (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), was reintroducted in the market....

Ablavar is a contrast agent approved for use with a magnetic resonance angiography (MRA) indication to evaluate aortoiliac occlusive disease (AIOD) and suspected peripheral vascular disease.

...

A new contrast-imaging agent for use with magnetic resonance angiography (MRA), ABLAVAR (gadofosveset trisodium), is indicated to evaluate aortoiliac occlusive disease (AIOD) in adults with known or s...

ABLAVAR (gadofosveset trisodium) is a blood pool contrast agent approved for magnetic resonance angiography to evaluate aortoiliac occlusive disease (AIOD) in patients with known or suspected peripher...

Vasovist Injection (gadofosveset trisodium), manufactured by EPIX Pharmaceuticals, is reportedly the first contrast imaging agent for use in patients undergoing magnetic resonance angiography (MRA).
...

The FDA approved for marketing EPIX Pharmaceuticals’ novel blood pool magnetic resonance angiography (MRA) agent, Vasovist (gadofosveset trisodium), to evaluate aortoiliac occlusive disease (AIOD) in ...

The Piccolo Xpress is designed to enable cardiologists to quickly run CLIA-waived Creatinine and BUN tests via the kidney check panel to assess renal function prior to administering contrast agents fo...

Lexiscan (regadenoson) injection is an A2A adenosine receptor agonist for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate ...

Bayer HealthCare Pharmaceuticals Inc....

Bayer Healthcare Pharmaceuticals responded to concerns by the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) on administering contrast agents by previewing at RSNA 2007 VistaTra...